SCHEMBL6696586

SCHEMBL6696586

COc1cccc2nc(N=C(N)N)nc(-c3ccccc3)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
RAD52 P43351 5/20 0.60
KMT2A Q03164 3/20 0.60
MEN1 O00255 2/20 0.60
MAPT P10636 1/20 0.60
KDM4E B2RXH2 6/20 0.53
POLB P06746 3/20 0.53
HTT P42858 1/20 0.53
MPO P05164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
DCPS Q96C86 1/20 0.43
HPGD P15428 2/20 0.40
ELANE P08246 1/20 0.40
PLAU P00749 1/20 0.40
SLC9A3 P48764 1/20 0.39
ATP4A P20648 1/20 0.39
ATP4B P51164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6693613 0.81 RAD52 (0.67) ALDH1A1RAD52KMT2AMEN1MAPT
SCHEMBL6692415 0.80 RAD52 (0.64) ALDH1A1RAD52KMT2AMEN1MAPT
SCHEMBL6693510 0.76 RAD52 (1.00) ALDH1A1RAD52KMT2AMEN1MAPT
SCHEMBL6695603 0.75 RAD52 (0.74) ALDH1A1RAD52KMT2AMEN1MAPT
SCHEMBL6696581 0.75 KDM4E (0.43) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL6692491 0.74 KMT2A (0.67) ALDH1A1RAD52KMT2AMEN1MAPT
Hydrochloric Acid SCHEMBL6712465 0.74 KDM4E (0.42) ALDH1A1KMT2AMEN1MAPTKDM4E
Hydrochloric Acid SCHEMBL6712462 0.74 KDM4E (0.42) ALDH1A1KMT2AMEN1MAPTKDM4E
Hydrochloric Acid SCHEMBL6712459 0.74 KDM4E (0.42) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL6695887 0.73 ALDH1A1 (0.67) ALDH1A1RAD52KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040224965-A1 2-Guanidino-4-arylchinazolines as nhe-3 inhibitors MERCK PATENT GMBH (DE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040224965-A1 2-Guanidino-4-arylchinazolines as nhe-3 inhibitors NHERF1, SLC9A3, SLC9A1 ALDH1A1 875/4885RAD52 4856/4885KMT2A 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.